A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
BOSTON (Reuters) - New ultra-sensitive blood tests can rapidly detect when heart muscle is dying from a heart attack, even from the moment the patient arrives in the emergency room, according to two ...
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
A single troponin level measurement test and an electrocardiogram may be sufficient to rule out the risk of a heart attack in patients complaining of chest pain, according to a study in the Journal of ...
Certain blood tests have been recalled due to risk for false negative or falsely low cardiac troponin levels. The FDA designated the recall as serious due to the risks of a missed or delayed MI ...
Background and Goal: Chest pain is a common but challenging symptom for general practitioners to evaluate, as it can be caused by both serious conditions and more benign issues. This study assessed ...
High-sensitivity cardiac troponin testing can identify patients with stable coronary artery disease who have a greater risk for MI or cardiovascular death, a study conducted in Scotland indicates.
Please provide your email address to receive an email when new articles are posted on . A point-of-care troponin test could reduce time patients with a heart attack spend in the ED by nearly 45 ...
Adding high-sensitivity cardiac troponin assays on top of conventional risk-prediction methods can potentially improve primary prevention efforts, according to a new meta-analysis. While best known ...
TARRYTOWN, N.Y.--(BUSINESS WIRE)--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test 1 immediately advances care for at-risk cardiac patients in the ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
A rapid heart attack test could significantly accelerate diagnosis and treatment for patients, experts have revealed, promising to cut waiting times in emergency departments. Suspected heart attacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback